Precision medicine including biomarkers is an increasingly important part of drug development.
A precision medicine strategy helps identify the:
right drug to the
right patient in the
right dose at the
right time and to the
A well planned and executed biomarker plan together with a robust understanding of your patient population, will take you closer to the final goal of evaluating the clinical potential of your lead compound or candidate drug.
- Biomarker identification and validation – We have extensive experience of biomarkers for many different purposes in drug development; target engagement, proof of mechanism (PoM), proof of principle (PoP), proof of concept (PoC) and precision medicine/patient stratification.
- Biomarker plan – Make sure the biomarker and the biomarker methods are fit-for-purpose and validated for the context of use. A biomarker plan that is linked to the Translational Medicine Plan and TPP helps you address critical questions and deliver the answers at the right time. This also creates possibilities for valuable bridging between animal models and early clinical trials in man.
- Preclinical Safety Evaluation plans – A safety plan helps you to foresee and mitigate risks and markedly increase the value of your project. The need for specific Safety biomarkers within your project can also be highlighted.
- Translational Medicine Plan (biomarkers & personalized medicine) – Integrates all aspects of translational medicine for your project, and provides clarity and line-of-sight. A translational medicine plan will help you integrate biomarker and patient stratification needs into your experimental and clinical plans.
- Target Product Profile (TPP) – A powerful tool in project management. Ensures full focus on the goal over time. Necessary in interactions with regulatory authorities, investors and clinical collaborators.
- Patient stratification studies – Do you really know who will benefit from your drug? We help you identify the relevant patient populations linked to your project strategy.